Molecular Partners AG
MLLCF
$4.22
-$0.06-1.40%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -100.00% | -54.10% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -100.00% | -54.10% | |||
| Cost of Revenue | -14.34% | -13.21% | |||
| Gross Profit | 8.61% | 7.71% | |||
| SG&A Expenses | 19.48% | 3.75% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.58% | -8.91% | |||
| Operating Income | 0.12% | 4.53% | |||
| Income Before Tax | 32.57% | -13.71% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 32.56% | -13.71% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 32.56% | -13.71% | |||
| EBIT | 0.12% | 4.53% | |||
| EBITDA | -2.36% | 4.80% | |||
| EPS Basic | 39.31% | -13.69% | |||
| Normalized Basic EPS | 39.32% | -13.69% | |||
| EPS Diluted | 38.94% | -13.69% | |||
| Normalized Diluted EPS | 39.32% | -13.69% | |||
| Average Basic Shares Outstanding | 11.12% | 0.04% | |||
| Average Diluted Shares Outstanding | 11.12% | 0.04% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||